The efficacy of the AMPA receptor antagonist ns1209 and lidocaine in nerve injury pain: A randomized, double-blind, placebo-controlled, three-way crossover study

Anesthesia and Analgesia

Volumn 108, Issue 4, 2009, Pages 1311-1319

  Gormsen, Lise ^a   Finnerup, Nanna B ^a   Almqvist, Per M ^b   Jensen, Troels S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NEUROSEARCH A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 (4 DIMETHYLSULFAMOYLPHENYL) 6,7,8,9 TETRAHYDRO 8 METHYL 2 OXO 1H PYRROLO[3,2 H]ISOQUINOLIN 3 YLIMINOXY] 4 HYDROXYBUTYRIC ACID; ACETYLSALICYLIC ACID; AMPA RECEPTOR; GABAPENTIN; LIDOCAINE; OXYCODONE; PARACETAMOL; PLACEBO; PREGABALIN; TRAMADOL; AMINO ACID RECEPTOR BLOCKING AGENT; GLUR5 KAINATE RECEPTOR; KAINIC ACID RECEPTOR; LOCAL ANESTHETIC AGENT; PYRROLE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ABNORMAL SENSATION; ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; INFUSION PUMP; MALE; MEMORY DISORDER; MUSCLE SPASM; NAUSEA; NEUROPATHIC PAIN; ORAL PARESTHESIA; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; XEROSTOMIA; ANALGESIA; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; HYPERALGESIA; INJURY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; NEURALGIA; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANALGESIA; ANESTHETICS, LOCAL; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPERALGESIA; INFUSIONS, INTRAVENOUS; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; PYRROLES; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; TETRAHYDROISOQUINOLINES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63849275646     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318198317b     Document Type: Article

References (24)

1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64
2. Bridges D, Thompson SW, Rice AS. Mechanisms of neuropathic pain. Br J Anaesth 2001;87:12-26
3. Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992;38:397-421
4. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993;52:259-85
5. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9
6. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9
7. Hains BC, Saab CY, Klein JP, Craner MJ, Waxman SG. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J Neurosci 2004;19:24:4832-9
8. Garry EM, Moss A, Rosie R, Delaney A, Mitchell R, Fleetwood- Walker SM. Specific involvement in neuropathic pain of AMPA receptors and adapter proteins for the GluR2 subunit. Mol Cell Neurosci 2003;24:10-22
9. Harris JA, Corsi M, Quartaroli M, Arban R, Bentivoglio M. Upregulation of spinal glutamate receptors in chronic pain. Neuroscience 1996;74:7-12
10. Popratiloff A, Weinberg RJ, Rustioni A. AMPA receptors at primary afferent synapses in substantia gelatinosa after sciatic nerve section. Eur J Neurosci 1998;10:3220-30
11. Cumberbatch MJ, Chizh BA, Headley PM. AMPA receptors have an equal role in spinal nociceptive and non-nociceptive transmission. Neuroreport 1994;5:877-80
12. Sang CN, Hostetter MP, Gracely RH, Chappell AS, Schoepp DD, Lee G, Whitcup S, Caruso R, Max MB. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans. Anesthesiology 1998;89:1060-7
13. Xu XJ, Seiger A, Wiesenfeld-Hallin Z. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats. J Pharmacol Exp Ther 1993;267:140-4
14. Simmons RM, Li DL, Hoo KH, Deverill M, Ornstein PL, Iyengar S. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 1998;37: 25-36
15. Pogatzki EM, Zahn PK, Brennan TJ. Effect of pretreatment with intrathecal excitatory amino acid receptor antagonists on the development of pain behavior caused by plantar incision. Anesthesiology 2000;93:489-96
16. Bennett AD, Everhart AW, Hulsebosch CE. Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury. Brain Res 2000;859:72-82
17. Gilron I, Max MB, Lee G, Booher SL, Sang CN, Chappell AS, Dionne RA. Effects of the 2-amino-3-hydroxy-5-methyl-4- isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain. Clin Pharmacol Ther 2000;68:320-7
18. Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Johnson KW, Phebus LA, Bleakman D, Ornstein PL, Arnold B, Tepper SJ, Vandenhende F. LY293558, a novel AMPA/GluR5 antagonist, is efficacious and welltolerated in acute migraine. Cephalalgia 2004;24:596-602
19. Finnerup NB, Biering-Sorensen F, Johannesen IL, Terkelsen AJ, Juhl GI, Kristensen AD, Sindrup SH, Bach FW, Jensen TS. Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anesthesiology 2005;102:1023-30
20. Gottrup H, Bach FW, Juhl G, Jensen TS. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anesthesiology 2006;104:527-36
21. Ben-Menachem EA. Phase 1, single center, open-label study to determine the cerebrospinal fluid (CSF) levels of NS1209 following an intravenous bolus/2- or 4-hours infusion of NS1209 in patients with epilepsy. NS1209-003. Neurosearch. Neurosearch report. 2008
22. Kvarnstrom A, Karlsten R, Quiding H, Emanuelsson BM, Gordh T. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesthesiol Scand 2003; 47:868-77
23. Jensen TS, Gottrup H, Sindrup SH, Bach FW. The clinical picture of neuropathic pain. Eur J Pharmacol 2001;19:429:1-11
24. Attal N, Rouaud J, Brasseur L, Chauvin M, Bouhassira D. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 2004;62:218-25